SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CuraGen (CRGN)
An SI Board Since March 1998
Posts SubjectMarks Bans Symbol
478 35 0 CRGN
Emcee:  Superhawk Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
328<i>Just came across this. Looked interesting:</i> United States Patnigel bates-9/11/2003
327The abstract has some details, such as dosage . . . >>Clinical Cancer Restuck-9/10/2003
326CuraGen Announces Study Demonstrating CG53135's Unique Activity in Two Animanigel bates-9/10/2003
325Recently published patent application relating to FGF-20 in inflammatory disordetuck-8/29/2003
324Company Says It Mapped Genes of Virus in One Day [NYT] By ANDREW POLLACK A smaDoc Bones-8/22/2003
323454 Life Sciences Completes First Whole Genome Sequence Using First Novel Technonigel bates-8/21/2003
322454 Life Sciences Obtains <b>Exclusive</b> License from Pyrosequencinigel bates-8/19/2003
321Nobody got around to posting the abstract on that FGF-20 study: >>Gastroetuck-7/23/2003
320>>Proc Natl Acad Sci U S A. 2003 Jul 17 [Epub ahead of print]. Predictituck-7/23/2003
319CuraGen Corp downgraded: Bear Stearns downgrades to Peer Perform from OutperformJim Oravetz-6/20/2003
318Restructuring again: NEW HAVEN, Conn., June 19 /PRNewswire-FirstCall/ -- CuraGenigel bates-6/19/2003
317CuraGen Announces Results of CR002 NEW HAVEN, Conn., June 9 /PRNewswire-FirstCanigel bates-6/9/2003
316CuraGen Reports First Quarter 2003 Financial Results - From Genome to Clinic: INnigel bates-4/24/2003
315Overall, mucositis affects approximately 15-40% of patients receiving standard-dJim Oravetz-3/4/2003
314NEW HAVEN, Conn., March 4 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq:nigel bates-3/4/2003
313They have somewhat north of $250 net cash (400 million less 150 million in convetuck-2/26/2003
312Mention made of CRGN in this article: Message 18601509 Anyone have any idea on Tomato-2/19/2003
311CuraGen 4Q Loss 59c/Shr DOW JONES NEWSWIRES <pre> CuraGen Corp. - New HaveJim Oravetz-1/30/2003
310Investor LeRoy Kopp Reports 5.3% Stake In Curagen DOW JONES NEWSWIRES WASHINGTOJim Oravetz-1/24/2003
309NEW HAVEN, Conn., and FREMONT, Calif., Jan. 9 /PRNewswire-FirstCall/ -- CuraGen nigel bates-1/9/2003
308Given their cash vs cap, it makes sense to me. If the market is happy to see thnigel bates-1/7/2003
307Probably no royalties are involved. Since the application of the technology comtuck-1/7/2003
306Maybe if they had mentioned the 'r' word ?nigel bates-1/7/2003
305Granted, this isn't a huge deal, but with the market mixed today, I am a bittuck-1/7/2003
304If you're too embarrassed to put out a PR, should you enter into the deal innigel bates-12/18/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News